dimethyl sulfone has been researched along with Sepsis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ao, S; Li, J; Liang, H; Liang, X; Liu, B; Liu, H; Ma, W; Tang, W; Xiao, H; Yang, X; Zhang, H; Zhou, J | 1 |
| Brito, GAC; da Silva, JA; de Medeiros, PHQS; Dos Santos, AA; Havt, A; Lima, AÂM; Prata, MMG; Rodrigues, FAP; Santos, ADDC; Santos, TCS; Silveira, ER | 1 |
2 other study(ies) available for dimethyl sulfone and Sepsis
| Article | Year |
|---|---|
Methylsulfonylmethane protects against lethal dose MRSA-induced sepsis through promoting M2 macrophage polarization.
Topics: Animals; Dimethyl Sulfoxide; Disease Models, Animal; Macrophage Activation; Macrophages; Methicillin-Resistant Staphylococcus aureus; Mice; Sepsis; Sulfones | 2022 |
Gingerol suppresses sepsis-induced acute kidney injury by modulating methylsulfonylmethane and dimethylamine production.
Topics: Acute Kidney Injury; Animals; Catechols; Dimethyl Sulfoxide; Dimethylamines; Disease Models, Animal; Fatty Alcohols; Feces; Humans; Injections, Intraperitoneal; Male; Metabolome; Metabolomics; Oxidative Stress; Peritonitis; Rats; Rats, Wistar; Sepsis; Sulfones; Survival Analysis; Treatment Outcome | 2018 |